DIVP - ETF AI Analysis
Top Page
Cullen Enhanced Equity Income ETF (DIVP)
Rating:71Outperform
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown steady gains so far this year and in recent months, indicating positive momentum.
Strong Top Holdings
Several of the largest positions, especially in health care and energy, have delivered strong returns, helping support the fund’s overall performance.
Broad Sector Diversification
The fund is spread across many sectors, including health care, energy, financials, consumer defensive, and utilities, which helps reduce the impact of weakness in any single industry.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not extremely high but is above what some low-cost index ETFs charge, slightly reducing net returns over time.
Heavy U.S. Concentration
The ETF is heavily focused on U.S. companies with only a small allocation to Canada, offering limited geographic diversification.
Mixed Performance Among Top Holdings
A few of the largest positions have shown weak or negative performance recently, which can drag on the fund’s overall results.
DIVP vs. SPDR S&P 500 ETF (SPY)
AUM59.63M
RegionNorth America
Expense Ratio0.55%
Beta0.43
IssuerCullen
Inception DateMar 06, 2024
Dividend Yield5.6%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,888
30 Day Avg. Volume6,192
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
31.17Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering35
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DIVP Summary
DIVP, the Cullen Enhanced Equity Income ETF, invests across the total U.S. stock market with a focus on both growth and steady income. It doesn’t track a specific index, but instead follows an equity income theme, choosing companies it believes can provide solid returns and regular payouts. The fund holds well-known names like UnitedHealth and Duke Energy, along with stocks from health care, energy, financials, and more, giving investors broad diversification. Someone might invest in DIVP to seek a mix of long-term growth and income, but should remember that its stock holdings can go up and down with the overall market.
How much will it cost me?The Cullen Enhanced Equity Income ETF (DIVP) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This expense ratio is higher than average for ETFs because it is actively managed, requiring more resources to implement its enhanced equity income strategy. Active management often involves more research and trading compared to passively managed funds, which track an index.
What would affect this ETF?The Cullen Enhanced Equity Income ETF (DIVP) could benefit from stable or improving economic conditions in the U.S., as its focus on income-producing assets and diverse sector exposure, including health care, financials, and consumer defensive, supports resilience and growth. However, rising interest rates or regulatory changes affecting key sectors like energy and financials may negatively impact its performance. Additionally, shifts in market sentiment toward income-focused strategies could influence investor demand for this ETF.
DIVP Top 10 Holdings
DIVP leans heavily on U.S. health care and energy names, and that’s where most of the story sits. Merck is one of the main engines, rising on solid results and a strong drug pipeline, while ConocoPhillips and EOG Resources are also pulling their weight as energy stays firm. On the health care side, UnitedHealth has been more mixed, occasionally losing steam, and Medtronic and Becton Dickinson have seen choppier, more uneven moves. AT&T adds a steady, income-focused tilt, but it’s not a big performance driver either way.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Conocophillips | 4.33% | $2.58M | $161.29B | 44.44% | 78 Outperform | |
| EOG Resources | 4.00% | $2.38M | $76.16B | 23.12% | 78 Outperform | |
| UnitedHealth | 3.76% | $2.24M | $356.47B | 25.92% | 72 Outperform | |
| Becton Dickinson | 3.65% | $2.17M | $50.32B | -3.98% | 67 Neutral | |
| Merck & Company | 3.58% | $2.13M | $370.89B | 77.46% | 80 Outperform | |
| Bristol-Myers Squibb | 3.58% | $2.13M | $136.49B | 41.75% | 78 Outperform | |
| Sysco | 3.45% | $2.05M | $38.35B | -2.91% | 71 Outperform | |
| Medtronic | 3.44% | $2.05M | $120.46B | 1.37% | 80 Outperform | |
| AT&T | 3.36% | $2.00M | $175.97B | -13.21% | 71 Outperform | |
| Exxon Mobil | 3.27% | $1.95M | $655.73B | 45.99% | 74 Outperform |
DIVP Technical Analysis
Positive
―
Price Trends
27.34
Positive
26.72
Positive
25.91
Positive
Market Momentum
0.08
Positive
52.47
Neutral
34.41
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVP, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.64, equal to the 50-day MA of 27.34, and equal to the 200-day MA of 25.91, indicating a neutral trend. The MACD of 0.08 indicates Positive momentum. The RSI at 52.47 is Neutral, neither overbought nor oversold. The STOCH value of 34.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVP.
DIVP Peer Comparison
Comparison Results
Performance Comparison
DIVP
Cullen Enhanced Equity Income ETF
27.60
3.80
15.97%
BAMD
Brookstone Dividend Stock ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
PFOE
Pathfinder Focused Opportunities ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
YALL
God Bless America ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents